After steadying during Q2, it appears the overall volume of deals in the healthcare industry declined in Q3 compared with Q2, and year-to-date 2023 is still down from last year, Bass, Berry & Sims notes in a new report.
A slumping economy has no doubt played a large role in the decline, and, as discussed in this report, the current regulatory environment is only exacerbating the situation. Many commentators believe the current slump may continue through 2024. The New York Federal Reserve did not allay these concerns when it announced last month that the U.S. is more likely than not (i.e., has a 56% chance) to fall into a recession by September 2024. The next quarter and indeed the next year, then, may continue to be highlighted by small, strategic expansions and creative cross-sector transactions. Read more.
